{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:44:28Z","timestamp":1790459068715,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":123,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540689607","type":"print"},{"value":"9783540689645","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/978-3-540-68964-5_14","type":"book-chapter","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T21:48:50Z","timestamp":1229464130000},"page":"309-339","source":"Crossref","is-referenced-by-count":131,"title":["NO- and Haem-Independent Soluble Guanylate Cyclase Activators"],"prefix":"10.1007","author":[{"given":"Harald H. H. W.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes-Peter","family":"Stasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"14_CR1_14","doi-asserted-by":"crossref","first-page":"L1117","DOI":"10.1152\/ajplung.00365.2001","volume":"283","author":"NG Abraham","year":"2002","unstructured":"Abraham NG, Quan S, Mieyal PA, Yang L, Burke-Wolin T, Mingone CJ, Goodman AI, Nasjletti A, Wolin MS (2002) Modulation of cGMP by human HO-1 retrovirus gene transfer in pulmonary microvessel endothelial cells. Am J Physiol Lung Cell Mol Physiol 283:L1117\u2013L1124","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"14_CR2_14","first-page":"19","volume":"37","author":"G Antonova","year":"2007","unstructured":"Antonova G, Lichtenbeld H, Xia T, Chatterjee A, Dimitropoulou C, Catravas JD (2007) Func tional significance of hsp90 complexes with NOS and sGC in endothelial cells. Clin Hemorheol Microcirc 37:19\u201335","journal-title":"Clin Hemorheol Microcirc"},{"key":"14_CR3_14","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1074\/jbc.M411545200","volume":"280","author":"N Balashova","year":"2005","unstructured":"Balashova N, Chang FJ, Lamothe M, Sun Q, Beuve A (2005) Characterization of a novel type of endogenous activator of soluble guanylyl cyclase. J Biol Chem 280:2186\u20132196","journal-title":"J Biol Chem"},{"key":"14_CR4_14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000104091","volume":"30","author":"K Benz","year":"2007","unstructured":"Benz K, Orth SR, Simonaviciene A, Linz W, Schindler U, R\u00fctten H, Amann K (2007) Blood pressure-independent effect of long-term treatment with the soluble heme-independent guany-lyl cyclase activator HMR1766 on progression in a model of noninflammatory chronic renal damage. Kidney Blood Press Res 30:224\u2013233","journal-title":"Kidney Blood Press Res"},{"key":"14_CR5_14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.cardiores.2007.04.014","volume":"75","author":"KD Bloch","year":"2007","unstructured":"Bloch KD, Ichinose F, Roberts JD Jr, Zapol WM (2007) Inhaled NO as a therapeutic agent. Car-diovasc Res 75:339\u2013348","journal-title":"Car-diovasc Res"},{"key":"14_CR6_14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/13543784.13.6.643","volume":"13","author":"G Boerrigter","year":"2004","unstructured":"Boerrigter G, Burnett JC Jr (2004) Recent advances in natriuretic peptides in congestive heart failure. Expert Opin Investig Drugs 13:643\u2013652","journal-title":"Expert Opin Investig Drugs"},{"key":"14_CR7_14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/HYPERTENSIONAHA.106.083832","volume":"49","author":"G Boerrigter","year":"2007a","unstructured":"Boerrigter G, Costello-Boerrigter LC, Cataliotti A, Lapp H, Stasch JP, Burnett JC Jr (2007a) Tar geting heme-oxidized soluble guanylate cyclase in experimental heart failure. Hypertension 49:1128\u20131133","journal-title":"Hypertension"},{"key":"14_CR8_14","first-page":"II-550","volume":"116","author":"G Boerrigter","year":"2007b","unstructured":"Boerrigter G, Costello-Boerrigter LC, Lapp H, Stasch JP, Burnett JC (2007b) Beneficial actions of co-targeting particulate and soluble guanylate cyclase dependent cGMP pools in experimental heart failure. Circulation 116 (Suppl):II-550","journal-title":"Circulation"},{"key":"14_CR9_14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjp.0707409","volume":"152","author":"DS Burley","year":"2007","unstructured":"Burley DS, Ferdinandy P, Baxter GF (2007) Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling. Br J Pharmacol 152:855\u2013869","journal-title":"Br J Pharmacol"},{"key":"14_CR10_14","doi-asserted-by":"crossref","first-page":"13064","DOI":"10.1073\/pnas.0506289102","volume":"102","author":"SP Cary","year":"2005","unstructured":"Cary SP, Winger JA, Marletta MA (2005) Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP. Proc Natl Acad Sci USA 102:13064\u201313069","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR11_14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pharmthera.2007.06.012","volume":"116","author":"YY Chirkov","year":"2007","unstructured":"Chirkov YY, Horowitz JD (2007) Impaired tissue responsiveness to organic nitrates and nitric oxide: A new therapeutic frontier? Pharmacol Ther 116:287\u2013305","journal-title":"Pharmacol Ther"},{"key":"14_CR12_14","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1161\/ATVBAHA.107.142943","volume":"27","author":"MP Coggins","year":"2007","unstructured":"Coggins MP, Bloch KD (2007) Nitric oxide in the pulmonary vasculature. Arterioscler Thromb Vasc Biol 27:1877\u20131885","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"14_CR13_14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.RES.0000178451.08719.5b","volume":"97","author":"ADT Costa","year":"2005","unstructured":"Costa ADT, Garlid KD, West IC, Lincoln TM, Downey JM, Cohen MV, Critz SD (2005) Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97:329\u2013 336","journal-title":"Circ Res"},{"key":"14_CR14_14","doi-asserted-by":"crossref","first-page":"35741","DOI":"10.1074\/jbc.M705557200","volume":"282","author":"ER Derbyshire","year":"2007","unstructured":"Derbyshire ER, Marletta MA (2007) Butyl isocyanide as a probe of the activation mechanism of soluble guanylate cyclase. Investigating the role of non-heme nitric oxide. J Biol Chem 282:35741\u201335748","journal-title":"J Biol Chem"},{"key":"14_CR15_14","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.105.581405","volume":"113","author":"R Dumitrascu","year":"2006","unstructured":"Dumitrascu R, Weissmann N, Ghofrani HA, Dony E, Beuerlein K, Schmidt HHHW, Stasch JP, Gnoth MJ, Seeger W, Grimminger F, Schermuly RT (2006) Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Circulation 113:286\u2013295","journal-title":"Circulation"},{"key":"14_CR16_14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2007.06.036","volume":"572","author":"TR Dunkern","year":"2007","unstructured":"Dunkern TR, Feurstein D, Rossi GA, Sabatini F, Hatzelmann A (2007) Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase. Eur J Pharmacol 572:12\u201322","journal-title":"Eur J Pharmacol"},{"key":"14_CR17_14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","volume":"5","author":"OV Evgenov","year":"2006","unstructured":"Evgenov OV, Pacher P, Schmidt PM, Hasko G, Schmidt HH, Stasch JP (2006) NO-independent stimulators and activators of soluble guanylate cyclase: Discovery and therapeutic potential. Nat Rev Drug Discov 5:755\u2013768","journal-title":"Nat Rev Drug Discov"},{"key":"14_CR18_14","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1164\/rccm.200707-1121OC","volume":"176","author":"OV Evgenov","year":"2007","unstructured":"Evgenov OV, Kohane DS, Bloch KD, Stasch JP, Volpato GP, Bellas E, Evgenov NV, Buys ES, Gnoth MJ, Graveline AR, Liu R, Hess DR, Langer R, Zapol EM (2007) Pulmonary vasodila-tion induced by inhalation of soluble guanylate cyclase agonists encapsulated into dry-powder microparticles. Am J Respir Crit Care Med 176:1138\u20131145","journal-title":"Am J Respir Crit Care Med"},{"key":"14_CR19_14","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.niox.2008.06.178","volume":"19","author":"OV Evgenov","year":"2008","unstructured":"Evgenov OV, Egorina EM, Stasch JP, Sovershaev MA (2008) Inhibition of expression and pro-coagulant activity of tissue factor by soluble guanylate cyclase agonists in monocytes and en-dothelial cells. Nitric Oxide. 19 (Suppl.): S61","journal-title":"Nitric Oxide"},{"key":"14_CR20_14","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","volume":"351","author":"HW Farber","year":"2004","unstructured":"Farber HW, Loscalzo J (2004) Pulmonary arterial hypertension. N Engl J Med 351:1655\u20131665","journal-title":"N Engl J Med"},{"key":"14_CR21_14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.embor.7400627","volume":"7","author":"R Feil","year":"2006","unstructured":"Feil R, Kemp-Harper B (2006) cGMP signalling: From bench to bedside. Conference on cGMP generators, effectors and therapeutic implications. EMBO Rep 7:149\u2013153","journal-title":"EMBO Rep"},{"key":"14_CR22_14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1432-1033.1996.0380h.x","volume":"240","author":"J Foerster","year":"1996","unstructured":"Foerster J, Harteneck C, Malkewitz J, Schultz G, Koesling D (1996) A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits. Eur J Biochem 240:380\u2013386","journal-title":"Eur J Biochem"},{"key":"14_CR23_14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuint.2004.03.026","volume":"45","author":"M Francois","year":"2004","unstructured":"Francois M, Kojda G (2004) Effect of hypercholesterolemia and of oxidative stress on the nitric oxide-cGMP pathway. Neurochem Int 45:955\u2013961","journal-title":"Neurochem Int"},{"issue":"Suppl 1","key":"14_CR24_14","first-page":"P453","volume":"97","author":"M Frenzel","year":"2008","unstructured":"Frenzel M, Methner C, Felix SB, Krieg T (2008) The guanylyl cyclase activator BAY 58\u20132667 protects isolated rat hearts against ischemia-reperfusion injury. Clin Res Cardiol 97 (Suppl 1):P453","journal-title":"Clin Res Cardiol"},{"key":"14_CR25_14","doi-asserted-by":"crossref","unstructured":"Frey R, M\u00fcck W, Unger S, Artmeier-Brandt U, Weimann G, Wensing G (2008) Pharmacokinet-ics, Pharmacodynamics, Tolerability and Safety of the Soluble Guanylate Cyclase Activator Cinaciguat (BAY 58\u20132667) in Healthy Male Volunteers. J Clin Pharmacol. 2008 Sep 8. [Epub ahead of print]","DOI":"10.1177\/0091270008322906"},{"key":"14_CR26_14","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1002\/j.1460-2075.1996.tb01078.x","volume":"15","author":"A Friebe","year":"1996","unstructured":"Friebe A, Schultz G, Koesling D (1996) Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J 15:6863\u20136868","journal-title":"EMBO J"},{"key":"14_CR27_14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/hep.20476","volume":"40","author":"SL Friedman","year":"2004","unstructured":"Friedman SL (2004) Stellate cells: A moving target in hepatic fibrogenesis. Hepatology 40: 1041\u20131003","journal-title":"Hepatology"},{"key":"14_CR28_14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0026-895X(25)10233-2","volume":"48","author":"J Garthwaite","year":"1995","unstructured":"Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B (1995) Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo [4,3-a]quinoxalin-1-one. Mol Pharmacol 48:184\u2013188","journal-title":"Mol Pharmacol"},{"key":"14_CR29_14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/089426802320282239","volume":"15","author":"T Gessler","year":"2002","unstructured":"Gessler T, Schmehl T, Olschewski H, Grimminger F, Seeger W (2002) Aerosolized vasodilators in pulmonary hypertension. J Aerosol Med 15:117\u2013122","journal-title":"J Aerosol Med"},{"key":"14_CR30_14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrd2030","volume":"5","author":"HA Ghofrani","year":"2006","unstructured":"Ghofrani HA, Osterloh IH, Grimminger F (2006) Sildenafil: From angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov 5:689\u2013702","journal-title":"Nat Rev Drug Discov"},{"key":"14_CR31_14","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1172\/JCI29807","volume":"116","author":"MT Gladwin","year":"2006","unstructured":"Gladwin MT (2006) Deconstructing endothelial dysfunction: Soluble guanylyl cyclase oxidation and the NO resistance syndrome. J Clin Invest 116:2330\u20132332","journal-title":"J Clin Invest"},{"key":"14_CR32_14","doi-asserted-by":"crossref","first-page":"P25","DOI":"10.1186\/1471-2210-7-S1-P25","volume":"7","author":"MG Hahn","year":"2007","unstructured":"Hahn MG, Alonso-Alija C, Stoll F, Heil M, Mittendorf J, Schlemmer KH, Wunder F, Stasch JP (2007) Design and synthesis of the first NO- and haem-independent sGC activator BAY 58\u2013 2667 for the treatment of acute decompensated heart failure. BMC Pharmacol 7:P25","journal-title":"BMC Pharmacol"},{"key":"14_CR33_14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI200524459","volume":"115","author":"JM Hare","year":"2005","unstructured":"Hare JM, Stamler JS (2005) NO\/Redox disequilibrium in the failing heart and cardiovascular sys tem. J Clin Invest 115:509\u2013517","journal-title":"J Clin Invest"},{"key":"14_CR34_14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0165-6147(97)90687-8","volume":"18","author":"AJ Hobbs","year":"1997","unstructured":"Hobbs AJ (1997) Soluble guanylate cyclase: The forgotten sibling. Trends Pharmacol Sci 18: 484\u2013491","journal-title":"Trends Pharmacol Sci"},{"key":"14_CR35_14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1517\/14728222.4.6.735","volume":"4","author":"AJ Hobbs","year":"2000","unstructured":"Hobbs AJ (2000) Soluble guanylate cyclase. Emerg Therap Targets 4:735\u2013749","journal-title":"Emerg Therap Targets"},{"key":"14_CR36_14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.bjp.0704779","volume":"136","author":"AJ Hobbs","year":"2002","unstructured":"Hobbs AJ (2002) Soluble guanylate cyclase: An old therapeutic target re-visited. Br J Pharmacol 136:637\u2013640","journal-title":"Br J Pharmacol"},{"key":"14_CR37_14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s001090050292","volume":"77","author":"M Hoenicka","year":"1999","unstructured":"Hoenicka M, Becker EM, Apeler H, Sirichoke T, Schroder H, Gerzer R, Stasch JP (1999) Purified soluble guanylyl cyclase expressed in a baculovirus\/Sf9 system: Stimulation by YC-1, nitric oxide, and carbon monoxide. J Mol Med 77:14\u201323","journal-title":"J Mol Med"},{"issue":"Suppl 1","key":"14_CR38_14","doi-asserted-by":"crossref","first-page":"P28","DOI":"10.1186\/1471-2210-7-S1-P28","volume":"7","author":"M Hoffmann","year":"2007","unstructured":"Hoffmann M, Thuss U (2007) Cardiovascular effects of the soluble guanylyl cyclase activator BAY 58\u20132667 in anesthetized dogs. BMC Pharmacol 7(Suppl 1):P28","journal-title":"BMC Pharmacol"},{"key":"14_CR39_14","doi-asserted-by":"crossref","unstructured":"Hoffmann LS, Keim Y, Schmidt PM, Sch\u00e4fer S, Schmidt HHHW, Stasch JP (2008) Distinct molec ular requirements to activate and stabilize soluble guanylate cyclase upon heme oxidation-induced degradation. Mol Pharmacol (under review)","DOI":"10.1186\/1471-2210-9-S1-P26"},{"key":"14_CR40_14","doi-asserted-by":"crossref","first-page":"F685","DOI":"10.1152\/ajprenal.00280.2004","volume":"288","author":"B Hohenstein","year":"2005","unstructured":"Hohenstein B, Daniel C, Wagner A, Stasch JP, Hugo C (2005) Stimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomeru-lonephritis. Am J Physiol Renal Physiol 288:F685\u2013F693","journal-title":"Am J Physiol Renal Physiol"},{"key":"14_CR41_14","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1073\/pnas.79.9.2870","volume":"79","author":"LJ Ignarro","year":"1982","unstructured":"Ignarro LJ, Wood KS, Wolin MS (1982) Activation of purified soluble guanylate cyclase by proto-porphyrin IX. Proc Natl Acad Sci USA 79:2870\u20132873","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR42_14","first-page":"267","volume":"17","author":"LJ Ignarro","year":"1984","unstructured":"Ignarro LJ, Wood KS, Wolin MS (1984) Regulation of purified soluble guanylate cyclase by por-phyrins and metalloporphyrins: A unifying concept. Adv Cyclic Nucl Protein Phosph Res 17:267\u2013274","journal-title":"Adv Cyclic Nucl Protein Phosph Res"},{"key":"14_CR43_14","doi-asserted-by":"crossref","first-page":"II-281","DOI":"10.1161\/CIRCULATIONAHA.106.628909","volume":"114","author":"SC Illiano","year":"2006","unstructured":"Illiano SC, Riva L, Bouloy M, Beauverger P, O'Connor SE (2006) Effect of HMR1766, a soluble guanylate cyclase activator, on differentiation of cardiac fibroblasts and extracellular matrix synthesis induced by TGFbeta. Circulation 114:II-281","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"14_CR44_14","first-page":"S362","volume":"26","author":"ES Jones","year":"2008","unstructured":"Jones ES, Kemp-Harper BA, Stasch JP, Schmidt HHHW, Widdop RE (2008) Beneficial cardiovas cular effects of chronic stimulation\/activation of sGC in aged spontaneously hypertensive rats. J Hypertens 26 (Suppl. 1):S362\u2013S363","journal-title":"J Hypertens"},{"key":"14_CR45_14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.bjp.0706792","volume":"148","author":"P Kalk","year":"2006","unstructured":"Kalk P, Godes M, Relle K, Rothkegel C, Hucke A, Stasch JP, Hocher B (2006) NO-independent ac tivation of soluble guanylate cyclase prevents disease progression in rats with 5\/6 nephrectomy. Br J Pharmacol 148:853\u2013859","journal-title":"Br J Pharmacol"},{"key":"14_CR46_14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/bbrc.1996.1786","volume":"229","author":"N Kawada","year":"1996","unstructured":"Kawada N, Kuroki T, Uoya M, Inue M, Kobayashi K (1996) Smooth muscle alpha actin expression in rat hepatic stellate cell is regulated by nitric oxide and cGMP production. Biochem Biophys Res Commun 229:238\u2013242","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"14_CR47_14","doi-asserted-by":"crossref","first-page":"pe12","DOI":"10.1126\/stke.19pe12","volume":"1","author":"B Kemp-Harper","year":"2008","unstructured":"Kemp-Harper B, Feil R. Meeting report: cGMP matters. Sci Signal. 2008 Mar 4; 1(9):pe12.","journal-title":"Sci Signal"},{"key":"14_CR48_14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1096\/fj.06-7526com","volume":"22","author":"M Kirsch","year":"2008","unstructured":"Kirsch M, Kemp-Harper B, Weissmann N, Grimminger F, Schmidt HHHW (2008) Sildenafil in hypoxic pulmonary hypertension potentiates a compensatory up-regulation of NO-cGMP sig naling. FASEB J 22:30\u201340","journal-title":"FASEB J"},{"key":"14_CR49_14","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(07)61634-1","volume":"370","author":"M Kitakaze","year":"2007","unstructured":"Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, Seguchi O, Myoishi M, Minamino T, Ohara T, Nagai Y, Nanto S, Watanabe K, Fukuzawa S, Hirayama A, Nakamura N, Kimura K, Fujii K, Ishihara M, Saito Y, Tomoike H, Kitamura S; J-WIND investigators (2007) Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet 370:1483\u20131493","journal-title":"Lancet"},{"key":"14_CR50_14","first-page":"71","volume":"58","author":"A Knorr","year":"2008","unstructured":"Knorr A, Hirth-Dietrich C, Alonso-Alija C, H\u00e4rter M, Hahn M, Keim Y, Wunder F, Stasch JP (2008) Nitric oxide-independent activation of soluble guanylate cyclase by BAY 60\u20132770 in experimental liver fibrosis. Arzneim.-Forsch.\/Drug Res 58:71\u201380","journal-title":"Arzneim.-Forsch.\/Drug Res"},{"key":"14_CR51_14","unstructured":"Krieg T, Liu Y, R\u00fctz T, Dost T, Yang XM, Stasch JP, Felix SB, Cohen MV, Downey JM (2009) Cardioprotective effects of the NO-independent guanylyl cyclase activator BAY 58\u20132667."},{"key":"14_CR52_14","doi-asserted-by":"crossref","first-page":"H1288","DOI":"10.1152\/ajpheart.00209.2008","volume":"295","author":"A Kuno","year":"2008","unstructured":"Kuno A, Solenkova NV, Solodushko V, Dost T, Liu Y, Yang XM, Cohen MV, Downey JM (2008) Infarct Limitation by a Protein Kinase G Activator at Reperfusion in Rabbit Hearts Is Depen dent on Sensitizing the Heart to A2b agonists by Protein Kinase C. Am J Physiol Heart Circ Physiol 295:H1288\u20131295","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Suppl 1","key":"14_CR53_14","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1471-2210-7-S1-S9","volume":"7","author":"H Lapp","year":"2007","unstructured":"Lapp H, Mitrovic V, Franz N, Heuer H, Buerke M, Wolfertz J, M\u00fcck W, Unger S, Wensing G, Frey R (2007) BAY 58\u20132667, a soluble guanylate cyclase activator, improves cardiopulmonary","journal-title":"BMC Pharmacol"},{"key":"14_CR54_14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10741-007-9016-3","volume":"12","author":"CY Lee","year":"2007","unstructured":"Lee CY, Burnett JC Jr (2007) Natriuretic peptides and therapeutic applications. Heart Fail Rev 12:131\u2013142","journal-title":"Heart Fail Rev"},{"key":"14_CR55_14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1124\/mol.104.001388","volume":"66","author":"TM Lincoln","year":"2004","unstructured":"Lincoln TM (2004) Cyclic GMP and phosphodiesterase 5 inhibitor therapies: What's on the hori zon? Mol Pharmacol 66:11\u201313","journal-title":"Mol Pharmacol"},{"key":"14_CR56_14","doi-asserted-by":"crossref","first-page":"7714","DOI":"10.1074\/jbc.274.12.7714","volume":"274","author":"R Makino","year":"1999","unstructured":"Makino R, Matsuda H, Obayashi E, Shiro Y, Iizuka T, Hori H (1999) EPR characterization of axial bond in metal center of native and cobalt-substituted guanylate cyclase. J Biol Chem 274: 7714\u20137723","journal-title":"J Biol Chem"},{"key":"14_CR57_14","doi-asserted-by":"crossref","first-page":"12938","DOI":"10.1073\/pnas.231486198","volume":"98","author":"E Martin","year":"2001","unstructured":"Martin E, Lee YC, Murad F (2001) YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components. Proc Natl Acad Sci USA 98: 12938\u201312942","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR58_14","doi-asserted-by":"crossref","first-page":"16671","DOI":"10.1073\/pnas.0405509101","volume":"101","author":"VO Melichar","year":"2004","unstructured":"Melichar VO, Behr-Roussel D, Zabel U, Uttenthal LO, Rodrigo J, Rupin A, Verbeuren TJ, Kumar HSA, Schmidt HHHW (2004) Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis. Proc Natl Acad Sci USA 101:16671\u201316676","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR59_14","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1172\/JCI27657","volume":"116","author":"E Mergia","year":"2006","unstructured":"Mergia E, Friebe A, Dangel O, Russwurm M, Koesling D (2006) Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system. J Clin Invest 116:1731\u20131737","journal-title":"J Clin Invest"},{"key":"14_CR60_14","unstructured":"Meurer S, Pioch S, Pabst T, Opitz N, Schmidt PM, Beckhaus T, Wagner K, Matt S, Gebauer K, Karas M, Stasch JP, Schmidt HHHW, M\u00fcller-Esterl W (2008) Heme-oxidized soluble guanylyl cyclase targeted to proteosomal degradation is rescued by NO-independent activator BAY 58\u2013 2667. Circ Res (under review)"},{"key":"14_CR61_14","doi-asserted-by":"crossref","first-page":"L337","DOI":"10.1152\/ajplung.00482.2005","volume":"291","author":"CJ Mingone","year":"2006","unstructured":"Mingone CJ, Gupte SA, Chow JL, Ahmad M, Abraham NG, Wolin MS (2006) Protoporphyrin IX generation from delta-aminolevulinic acid elicits pulmonary artery relaxation and soluble guanylate cyclase activation. Am J Physiol Lung Cell Mol Physiol 291:L337\u2013L344","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"14_CR62_14","doi-asserted-by":"crossref","first-page":"H1244","DOI":"10.1152\/ajpheart.00846.2007","volume":"294","author":"CJ Mingone","year":"2008","unstructured":"Mingone CJ, Ahmad M, Gupte SA, Chow JL, Wolin MS (2008) Heme oxygenase-1 induction depletes heme and attenuates pulmonary artery relaxation and guanylate cyclase activation by nitric oxide. Am J Physiol Heart Circ Physiol 294:H1244\u2013H1250","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"14_CR63_14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00395-008-0743-y","volume":"103","author":"T Miura","year":"2008","unstructured":"Miura T, Miki T (2008) Limitation of myocardial infarct size in the clinical setting: current sta tus and challenges in translating animal experiments into clinical therapy. Basic Res Cardiol 103:501\u2013513","journal-title":"Basic Res Cardiol"},{"key":"14_CR64_14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/3-540-32967-6_7","volume":"176","author":"S Moncada","year":"2006","unstructured":"Moncada S and Higgs EA (2006) Nitric oxide and the vascular endothelium. Handb Exp Pharmacol 176:213\u2013254","journal-title":"Handb Exp Pharmacol"},{"key":"14_CR65_14","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/HYPERTENSIONAHA.106.085456","volume":"49","author":"T M\u00fcnzel","year":"2007","unstructured":"M\u00fcnzel T, Genth-Zotz S, Hink U (2007) Targeting heme-oxidized soluble guanylate cyclase: Solution for all cardiorenal problems in heart failure? Hypertension 49:974\u2013976","journal-title":"Hypertension"},{"key":"14_CR66_14","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMsa063904","volume":"355","author":"F Murad","year":"2006","unstructured":"Murad F (2006) Shattuck lecture. Nitric oxide and cyclic GMP in cell signaling and drug develop ment. N Engl J Med 355:2003\u20132011","journal-title":"N Engl J Med"},{"key":"14_CR67_14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1124\/jpet.107.132928","volume":"325","author":"KS Murthy","year":"2008","unstructured":"Murthy KS (2008) Inhibitory phosphorylation of soluble guanylyl cyclase by muscarinic m2 re ceptors via G\u03b2\u03b3-dependent activation of c-Src kinase. J Pharmacol Exp Ther 325:183\u2013189","journal-title":"J Pharmacol Exp Ther"},{"key":"14_CR68_14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.febslet.2007.12.025","volume":"582","author":"PI Nedvetsky","year":"2008","unstructured":"Nedvetsky PI, Meurer S, Opitz N, Nedvetskaya TY, Muller H, Schmidt HHHW (2008) Heat shock protein 90 regulates stabilization rather than activation of soluble guanylate cyclase. FEBS Lett 582:327\u2013331","journal-title":"FEBS Lett"},{"key":"14_CR69_14","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.drudis.2007.10.004","volume":"12","author":"U Nielsch","year":"2008","unstructured":"Nielsch U, Sch\u00e4fer S, Wild H, Busch A (2008) One target-multiple indications: A call for an integrated common mechanisms strategy. Drug Discov Today 12:1025\u20131031","journal-title":"Drug Discov Today"},{"key":"14_CR70_14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0091270006294540","volume":"47","author":"H Oberwittler","year":"2007","unstructured":"Oberwittler H, Hirschfeld-Warneken A, Wesch R, Willerich H, Teichert L, Lehr KH, Ding R, Haefeli WE, Mikus G (2007) Significant pharmacokinetic and pharmacodynamic interaction of warfarin with the NO-independent sGC activator HMR1766. J Clin Pharmacol 47:70\u201377","journal-title":"J Clin Pharmacol"},{"key":"14_CR71_14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87nd peroxynitrite in health and disease Physiol Rev 87:315\u2013424","journal-title":"Physiol Rev"},{"key":"14_CR72_14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1124\/mol.105.012682","volume":"68","author":"A Papapetropoulos","year":"2005","unstructured":"Papapetropoulos A, Zhou Z, Gerassimou C, Yetik G, Venema RC, Roussos C, Sessa WC, Catravas JD (2005) Interaction between the 90-kDa heat shock protein and soluble guanylyl cyclase: Physiological significance and mapping of the domains mediating binding. Mol Phar macol 68:1133\u20131141","journal-title":"Mol Phar macol"},{"key":"14_CR73_14","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1378\/chest.06-3087","volume":"132","author":"NM Patel","year":"2007","unstructured":"Patel NM, Lederer DJ, Borczuk AC, Kawut SM (2007) Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 132:998\u20131006","journal-title":"Chest"},{"key":"14_CR74_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrd2153","volume":"6","author":"JS Paton","year":"2007","unstructured":"Paton JS, Byron PR (2007) Inhaling medicines: Delivering drugs to the body through the lungs. Nat Rev Drug Discov 6:67\u201374","journal-title":"Nat Rev Drug Discov"},{"key":"14_CR75_14","doi-asserted-by":"crossref","first-page":"12854","DOI":"10.1073\/pnas.0405188101","volume":"101","author":"P Pellicena","year":"2004","unstructured":"Pellicena P, Karow DS, Boon EM, Marletta MA, Kuriyan J (2004) Crystal structure of an oxygen-binding heme domain related to soluble guanylate cyclases. Proc Natl Acad Sci USA 101:12854\u201312859","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR76_14","first-page":"L337","volume":"29","author":"WJ Perkins","year":"2006","unstructured":"Perkins WJ (2006) Regulation of soluble guanylyl cyclase: Looking beyond NO. Am J Physiol Lung Cell Mol Physiol 29:L337\u2013L344","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"14_CR77_14","doi-asserted-by":"crossref","first-page":"G535","DOI":"10.1152\/ajpgi.00297.2005","volume":"290","author":"RE Perri","year":"2006","unstructured":"Perri RE, Langer DA, Chatterjee S, Gibbons SJ, Gadgil J, Cao S, Farrugia G, Shah VH (2006) Defects in cGMP-PKG pathway contribute to impaired NO-dependent responses in hepatic stellate cells upon activation. Am J Physiol Gastrointest Liver Physiol 290:G535\u2013G542","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"14_CR78_14","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/j.1523-1755.2004.66012.x","volume":"66","author":"H Peters","year":"2004","unstructured":"Peters H, Wang Y, Loof T, Martini S, Kron S, Kr\u00e4mer S, Neumayer HH (2004) Expression and ac tivity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis. Kidney Int 66:2224\u20132236","journal-title":"Kidney Int"},{"key":"14_CR79_14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10557-008-6098-7","volume":"22","author":"S Rajendran","year":"2008","unstructured":"Rajendran S, Chirkov YY (2008) Platelet hyperaggregability: impaired responsiveness to nitric oxide (\u201cplatelet NO resistance\u201d) as a therapeutic target. Cardiovasc Drugs Ther. 22:193\u2013203.","journal-title":"Cardiovasc Drugs Ther"},{"key":"14_CR80_14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.50.4.571","volume":"50","author":"H Reynaert","year":"2002","unstructured":"Reynaert H, Thompson MG, Thomas T, Geerts A (2002) Hepatic stellate cells: Role in microcir-culation and pathophysiology of portal hypertension. Gut 50:571\u2013581","journal-title":"Gut"},{"key":"14_CR81_14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1681\/ASN.2007010103","volume":"18","author":"E Ritz","year":"2007","unstructured":"Ritz E (2007) Endothelial cell dysfunction\u2014can one outsmart oxidative stress by direct interaction with the pathological oxidized or heme-free soluble guanylate cyclase? J Am Soc Nephrol 18:663\u2013666","journal-title":"J Am Soc Nephrol"},{"key":"14_CR82_14","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1016\/j.febslet.2006.06.079","volume":"580","author":"C Rothkegel","year":"2006","unstructured":"Rothkegel C, Schmidt PM, Stoll F, Schr\u00f6der H, Schmidt HH, Stasch JP (2006) Identification of residues crucially involved in soluble guanylate cyclase activation. FEBS Lett 580:4205\u20134213","journal-title":"FEBS Lett"},{"key":"14_CR83_14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.107.036368","volume":"72","author":"C Rothkegel","year":"2007","unstructured":"Rothkegel C, Schmidt PM, Atkins DJ, Hoffmann LS, Schmidt HHHW, Schr\u00f6der H, Stasch JP (2007) Dimerization region of soluble guanylate cyclase characterized by bimolecular fluores cence complementation in vivo. Mol Pharmacol 72:1181\u20131190","journal-title":"Mol Pharmacol"},{"key":"14_CR84_14","doi-asserted-by":"crossref","first-page":"12185","DOI":"10.1073\/pnas.0602544103","volume":"103","author":"B Roy","year":"2006","unstructured":"Roy B, Garthwaite J (2006) Nitric oxide activation of guanylyl cyclase in cells revisited. Proc Natl Acad Sci USA 103:12185\u201312190","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR85_14","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/sj.bjp.0707687","volume":"153","author":"B Roy","year":"2008","unstructured":"Roy B, Mo E, Vernon J, Garthwaite J (2008) Probing the presence of the ligand-binding haem in cellular nitric oxide receptors. Br J Pharmacol 153:1495\u20131504","journal-title":"Br J Pharmacol"},{"key":"14_CR86_14","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.RES.85.6.534","volume":"85","author":"H Ruetten","year":"1999","unstructured":"Ruetten H, Zabel U, Linz W, Schmidt HHHW (1999) Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ Res 85:534\u2013541","journal-title":"Circ Res"},{"key":"14_CR87_14","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1038\/sj.emboj.7600422","volume":"23","author":"M Russwurm","year":"2004","unstructured":"Russwurm M, Koesling D (2004) NO activation of guanylyl cyclase. EMBO J 23:4443\u20134450","journal-title":"EMBO J"},{"key":"14_CR88_14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.yjmcc.2006.10.015","volume":"42","author":"FN Salloum","year":"2007","unstructured":"Salloum FN, Takenoshita Y, Ockaili RA, Daoud VP, Chou E, Yoshida K, Kukreja RC (2007) Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial KATPchannels when administered at reperfusion following ischemia in rabbits. J Mol Cell Cardiol 42:453\u2013458","journal-title":"J Mol Cell Cardiol"},{"key":"14_CR89_14","doi-asserted-by":"crossref","first-page":"H1398","DOI":"10.1152\/ajpheart.ajpheart.91438.2007","volume":"294","author":"FN Salloum","year":"2008","unstructured":"Salloum FN, Abbate A, Das A, Houser JE, Mudrick CA, Qureshi IZ, Hoke NN, Roy SK, Brown WR, Prabhakar S, Kukreja RC (2008) Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice. Am J Physiol Heart Circ Physiol. 294:H1398\u2013 1406.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"14_CR90_14","doi-asserted-by":"crossref","first-page":"12312","DOI":"10.1073\/pnas.0703944104","volume":"104","author":"N Sayed","year":"2007","unstructured":"Sayed N, Baskaran P, Ma X, van den Akker F, Beuve A (2007) Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA 104:12312\u201312317","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR91_14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1358\/dof.2007.032.08.1112504","volume":"32","author":"A Sch\u00e4fer","year":"2007","unstructured":"Sch\u00e4fer A, Bauersachs J (2007) Therapeutic targets of ataciguat. Drugs Fut 32:731\u2013738","journal-title":"Drugs Fut"},{"key":"14_CR92_14","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1161\/01.ATV.0000249407.92147.12","volume":"26","author":"A Sch\u00e4fer","year":"2006","unstructured":"Sch\u00e4fer A, Flierl U, Kobsar A, Eigenthaler M, Ertl G, Bauersachs J (2006) Soluble guanylyl cyclase activation with HMR1766 attenuates platelet activation in diabetic rats. Arterioscler Thromb Vasc Biol 26:2813\u20132818","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"14_CR93_14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1183\/09031936.00114407","volume":"32","author":"RT Schermuly","year":"2008","unstructured":"Schermuly RT, Stasch JP, Pullamsetti SS, Middendorff R, M\u00fcller D, Schl\u00fcter KD, Dingendorf A, Hackemack S, Kolosionek E, Kaulen C, Dumitrascu R, Weissmann N, Mittendorf J, Klepetko W, Seeger W, Ghofrani HA, Grimminger F (2008) Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. Eur Respir J 32:881\u2013891.","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"14_CR94_14","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1186\/1471-2210-5-S1-S19","volume":"5","author":"U Schindler","year":"2005","unstructured":"Schindler U, Klein M, Linz W, R\u00fctten H, Sch\u00e4fer S, Strobel H, Sch\u00e4fer A, Bauersachs J, Wassmann S, Van Eickels M (2005) Role of activators of ferric sGC in cardiovascular disease. BMC Pharmacol 5(Suppl 1):S19","journal-title":"BMC Pharmacol"},{"key":"14_CR95_14","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1124\/mol.105.018747","volume":"69","author":"U Schindler","year":"2006","unstructured":"Schindler U, Strobel H, Schonafinger K, Linz W, Lohn M, Martorana PA, Rutten H, Schindler PW, Busch AE, Sohn M, Topfer A, Pistorius A, Jannek C, Mulsch A (2006) Biochemistry and pharmacology of novel anthranilic acid derivatives activating heme-oxidized soluble guanylyl cyclase. Mol Pharmacol 69:1260\u20131268","journal-title":"Mol Pharmacol"},{"key":"14_CR96_14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0014-2999(03)01674-1","volume":"468","author":"P Schmidt","year":"2003a","unstructured":"Schmidt P, Schramm M, Schroder H, Stasch JP (2003a) Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase. Eur J Pharmacol 468:167\u2013174","journal-title":"Eur J Pharmacol"},{"key":"14_CR97_14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1046-5928(03)00142-6","volume":"31","author":"P Schmidt","year":"2003b","unstructured":"Schmidt P, Schramm M, Schr\u00f6der H, Stasch JP (2003b) Preparation of heme-free soluble guanylate cyclase. Protein Expr Purif 31:42\u201346","journal-title":"Protein Expr Purif"},{"key":"14_CR98_14","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1074\/jbc.M310141200","volume":"279","author":"PM Schmidt","year":"2004","unstructured":"Schmidt PM, Schramm M, Schroder H, Wunder F, Stasch JP (2004) Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase. J Biol Chem 279:3025\u20133032","journal-title":"J Biol Chem"},{"key":"14_CR99_14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2005.02.046","volume":"513","author":"PM Schmidt","year":"2005","unstructured":"Schmidt PM, Rothkegel C, Wunder F, Schroder H, Stasch JP (2005) Residues stabilizing the heme moiety of the nitric oxide sensor soluble guanylate cyclase. Eur J Pharmacol 513:67\u201374","journal-title":"Eur J Pharmacol"},{"key":"14_CR100_14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35065611","volume":"410","author":"JP Stasch","year":"2001","unstructured":"Stasch JP, Becker EM, Alonso-Alija C, Apeler H, Dembowsky K, Feurer A, Gerzer R, Minuth T, Perzborn E, Plei\u03b2 U, Schr\u00f6der H, Schroeder W, Stahl E, Steinke W, Straub A, Schramm M (2001) NO-independent regulatory site on soluble guanylate cyclase. Nature 410:212\u2013215","journal-title":"Nature"},{"key":"14_CR101_14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/sj.bjp.0704778","volume":"136","author":"JP Stasch","year":"2002a","unstructured":"Stasch JP, Schmidt P, Alonso-Alija C, Apeler H, Dembowsky K, Haerter M, Heil M, Minuth T, Perzborn E, Pleiss U, Schramm M, Schroeder W, Schroder H, Stahl E, Steinke W, Wunder F (2002a) NO- and haem-independent activation of soluble guanylyl cyclase: Molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol 136:773\u2013783","journal-title":"Br J Pharmacol"},{"key":"14_CR102_14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/sj.bjp.0704484","volume":"135","author":"JP Stasch","year":"2002b","unstructured":"Stasch JP, Alonso-Alija C, Apleler H, Dembowsky K, Feurer A, Minuth T, Perzborn E, Schramm M, Straub A (2002b) Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41\u20138543: In vitro studies. Br J Pharmacol 135:333\u2013343","journal-title":"Br J Pharmacol"},{"key":"14_CR103_14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjp.0704483","volume":"135","author":"JP Stasch","year":"2002c","unstructured":"Stasch JP, Dembowsky K, Perzborn E, Stahl E, Schramm M (2002c) Cardiovascular actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41\u20138543: In vivo studies. Br J Phar macol 135:344\u2013355","journal-title":"Br J Phar macol"},{"key":"14_CR104_14","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","volume":"116","author":"JP Stasch","year":"2006","unstructured":"Stasch JP, Schmidt PM, Nedvetsky PI, Nedvetskaya TY, Kumar A, Meurer S, Deile M, Taye A, Knorr A, Lapp H, M\u00fcller H, Turgay Y, Rothkegel C, Tersteegen A, Kemp-Harper B, M\u00fcller-Esterl W, Schmidt HHHW (2006) Targeting the heme-oxidized nitric oxide receptor for selec tive vasodilatation of diseased blood vessels. J Clin Invest 116:2552\u20132561","journal-title":"J Clin Invest"},{"key":"14_CR105_14","doi-asserted-by":"crossref","unstructured":"Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Shekerdemian LS (2003) Intravenous sildenafil and inhaled nitric oxide: A randomised trial in infants after cardiac surgery. Intensive Care Med 1996\u20132003","DOI":"10.1007\/s00134-003-2016-4"},{"key":"14_CR106_14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1568016043356200","volume":"2","author":"DA Tulis","year":"2007","unstructured":"Tulis DA (2007) Salutary properties of YC-1 in the cardiovascular and hematological systems. Curr Med Chem Cardiovasc Hematol Agents 2:343\u2013359","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"key":"14_CR107_14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/gut.51.3.440","volume":"51","author":"M Casteele Van de","year":"2002","unstructured":"Van de Casteele M, Omasta A, Janssens S, Roskams T, Desmet V, Nevens F, Fevery J (2002) In vivo gen transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetized CCl4 cirrhotic rats. Gut 51:440\u2013445","journal-title":"Gut"},{"key":"14_CR108_14","doi-asserted-by":"crossref","first-page":"H669","DOI":"10.1152\/ajpheart.01025.2002","volume":"285","author":"RC Venema","year":"2003","unstructured":"Venema RC, Venema VJ, Ju H, Harris MB, Snead C, Jilling T, Dimitropoulou C, Maragoudakis ME, Catravas JD (2003) Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am J Physiol Heart Circ Physiol 285:H669\u2013H678","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"14_CR109_14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1523-1755.2005.00380.x","volume":"68","author":"Y Wang","year":"2005","unstructured":"Wang Y, Kr\u00e4mer S, Loof T, Martini S, Kron S, Kawachi H, Shimizu F, Neumayer HH, Peters H (2005) Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis. Kidney Int 68:47\u201361","journal-title":"Kidney Int"},{"key":"14_CR110_14","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1152\/ajprenal.00197.2005","volume":"290","author":"Y Wang","year":"2006","unstructured":"Wang Y, Kr\u00e4mer S, Loof T, Martini S, Kron S, Kawachi H, Shimizu F, Neumayer HH, Peters H (2006) Enhancing cGMP in experimental progressive renal fibrosis: Soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition. Am J Physiol Renal Physiol 290:F167\u2013F176","journal-title":"Am J Physiol Renal Physiol"},{"key":"14_CR111_14","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.2174\/092986708784567725","volume":"15","author":"Y Wang-Rosenke","year":"2008","unstructured":"Wang-Rosenke Y, Neumayer HH, Peters H (2008) NO signaling through cGMP in renal tissue fibrosis and beyond: Key pathway and novel therapeutic target. Curr Med Chem 15:1396\u20131406","journal-title":"Curr Med Chem"},{"key":"14_CR112_14","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0891-5849(01)00706-7","volume":"31","author":"M Weber","year":"2001","unstructured":"Weber M, Lauer N, Mulsch A, Kojda G (2001) The effect of peroxynitrite on the catalytic activity of soluble guanylyl cyclase. Free Radic Biol Med 31:1360\u20131367","journal-title":"Free Radic Biol Med"},{"key":"14_CR113_14","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1073\/pnas.91.7.2592","volume":"91","author":"B Wedel","year":"1994","unstructured":"Wedel B, Humbert P, Harteneck C, Foerster J, Malkewitz J, Bohme E, Schultz G, Koesling D (1994) Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc Natl Acad Sci USA 91:2592\u20132596","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR114_14","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/00000542-200006000-00030","volume":"92","author":"J Weimann","year":"2000","unstructured":"Weimann J, Ullrich R, Hromi J, Fujino Y, Clark MW, Bloch KD, Zapol WM (2000) Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. Anesthesiology 92:1702\u20131712","journal-title":"Anesthesiology"},{"key":"14_CR115_14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ab.2004.12.025","volume":"339","author":"F Wunder","year":"2005","unstructured":"Wunder F, Stasch JP, Hutter J, Alonso-Alija C, Huser J, Lohrmann E (2005) A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide\/cGMP pathway. Anal Biochem 339:104\u2013112","journal-title":"Anal Biochem"},{"key":"14_CR116_14","doi-asserted-by":"crossref","first-page":"H3080","DOI":"10.1152\/ajpheart.00579.2007","volume":"293","author":"T Xia","year":"2007","unstructured":"Xia T, Dimitropoulou C, Zeng J, Antonova GN, Snead C, Venema RC, Fulton D, Qian S, Patterson C, Papapetropoulos A, Catravas JD (2007) Chaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclase. Am J Physiol Heart Circ Physiol 293:H3080\u2013H3087","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"14_CR117_14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00395-006-0587-2","volume":"101","author":"XM Yang","year":"2006","unstructured":"Yang XM, Philipp S, Downey JM, Cohen MV (2006) Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts. Basic Res Cardiol 101:311\u201318","journal-title":"Basic Res Cardiol"},{"key":"14_CR118_14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1152\/physrev.00009.2003","volume":"83","author":"DM Yellon","year":"2003","unstructured":"Yellon DM, Downey JM (2003) Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83:1113\u20131151","journal-title":"Physiol Rev"},{"key":"14_CR119_14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ncb775","volume":"4","author":"U Zabel","year":"2002","unstructured":"Zabel U, Kleinschnitz C, Oh P, Smolenski A, Nedvetsky P, Kugler P, Walter U, Schnitzer JE,Schmidt HHHW (2002) Calcium-dependent membrane association sensitises soluble guanylyl cyclase to NO. Nat Cell Biol 4:307\u2013311","journal-title":"Nat Cell Biol"},{"key":"14_CR120_14","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1021\/bi972686m","volume":"37","author":"Y Zhao","year":"1998","unstructured":"Zhao Y, Schelvis JP, Babcock GT, Marletta MA (1998) Identification of histidine 105 in the beta1 subunit of soluble guanylate cyclase as the heme proximal ligand. Biochemistry 37:4502\u20134509","journal-title":"Biochemistry"},{"key":"14_CR121_14","doi-asserted-by":"crossref","first-page":"14753","DOI":"10.1073\/pnas.96.26.14753","volume":"96","author":"Y Zhao","year":"1999","unstructured":"Zhao Y, Brandish PE, Ballou DP, Marletta MA (1999) A molecular basis for nitric oxide sensing by soluble guanylate cyclase. Proc Natl Acad Sci USA 96:14753\u201314758","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR122_14","doi-asserted-by":"crossref","first-page":"10848","DOI":"10.1021\/bi9929296","volume":"39","author":"Y Zhao","year":"2000","unstructured":"Zhao Y, Brandish PE, DiValentin M, Schelvis JP, Babcock GT, Marletta MA (2000) Inhibition of soluble guanylate cyclase by ODQ. Biochemistry 39:10848\u201310854","journal-title":"Biochemistry"},{"key":"14_CR123_14","doi-asserted-by":"crossref","unstructured":"Zhou Z, Pyriochou A, Kotanidou A, Dalkas G, Eickels MV, Spyroulias G, Roussos C, Papapetropoulos A (2008) Soluble guanylyl cyclase (sGC) activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress. Am J Physiol Heart Circ Physiol. H1763\u20131771.","DOI":"10.1152\/ajpheart.51.2008"}],"container-title":["Handbook of Experimental Pharmacology","cGMP: Generators, Effectors and Therapeutic Implications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-540-68964-5_14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T06:32:17Z","timestamp":1738823537000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-540-68964-5_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["9783540689607","9783540689645"],"references-count":123,"URL":"https:\/\/doi.org\/10.1007\/978-3-540-68964-5_14","relation":{},"ISSN":["0171-2004"],"issn-type":[{"value":"0171-2004","type":"print"}],"subject":[]}}